Anti-CCL3/ G0S19-1/ LD78ALPHA functional antibody

Anti-CCL3/ G0S19-1/ LD78ALPHA functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CCL3/CCL3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T97765-Ab-1/ GM-Tg-hg-T97765-Ab-2Anti-Human CCL3 monoclonal antibodyHuman
GM-Tg-rg-T97765-Ab-1/ GM-Tg-rg-T97765-Ab-2Anti-Rat CCL3 monoclonal antibodyRat
GM-Tg-mg-T97765-Ab-1/ GM-Tg-mg-T97765-Ab-2Anti-Mouse CCL3 monoclonal antibodyMouse
GM-Tg-cynog-T97765-Ab-1/ GM-Tg-cynog-T97765-Ab-2Anti-Cynomolgus/ Rhesus macaque CCL3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T97765-Ab-1/ GM-Tg-felg-T97765-Ab-2Anti-Feline CCL3 monoclonal antibodyFeline
GM-Tg-cang-T97765-Ab-1/ GM-Tg-cang-T97765-Ab-2Anti-Canine CCL3 monoclonal antibodyCanine
GM-Tg-bovg-T97765-Ab-1/ GM-Tg-bovg-T97765-Ab-2Anti-Bovine CCL3 monoclonal antibodyBovine
GM-Tg-equg-T97765-Ab-1/ GM-Tg-equg-T97765-Ab-2Anti-Equine CCL3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T97765-Ab-1/ GM-Tg-hg-T97765-Ab-2; GM-Tg-rg-T97765-Ab-1/ GM-Tg-rg-T97765-Ab-2;
GM-Tg-mg-T97765-Ab-1/ GM-Tg-mg-T97765-Ab-2; GM-Tg-cynog-T97765-Ab-1/ GM-Tg-cynog-T97765-Ab-2;
GM-Tg-felg-T97765-Ab-1/ GM-Tg-felg-T97765-Ab-2; GM-Tg-cang-T97765-Ab-1/ GM-Tg-cang-T97765-Ab-2;
GM-Tg-bovg-T97765-Ab-1/ GM-Tg-bovg-T97765-Ab-2; GM-Tg-equg-T97765-Ab-1/ GM-Tg-equg-T97765-Ab-2
Products NameAnti-CCL3 monoclonal antibody
Formatmab
Target NameCCL3
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CCL3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T97765-Ag-1Recombinant multi-species CCL3/ G0S19-1/ LD78ALPHA protein
    CytokineGM-Tg-g-T97765-Ag-1chemokine (C-C motif) ligand 3 (CCL3) protein
    ORF Viral VectorpGMLP003374human CCL3 Lentivirus plasmid
    ORF Viral VectorvGMLP003374human CCL3 Lentivirus particle
    ORF Viral VectorpGMLPm001873mouse Ccl3 Lentivirus plasmid
    ORF Viral VectorvGMLPm001873mouse Ccl3 Lentivirus particle


    Target information

    Target IDGM-T97765
    Target NameCCL3
    Gene ID6348
    Gene Symbol and SynonymsCCL3,G0S19-1,LD78ALPHA,MIP-1-alpha,MIP1A,SCYA3
    Uniprot AccessionP10147
    Uniprot Entry NameCCL3_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryTherapeutics Target, Cytokine Target
    DiseaseCancer
    Gene EnsemblENSG00000277632
    Target ClassificationTumor-associated antigen (TAA)

    The target: CCL3, gene name: CCL3, also named as G0S19-1, LD78ALPHA, MIP-1-alpha, MIP1A, SCYA3. This locus represents a small inducible cytokine. The encoded protein, also known as macrophage inflammatory protein 1 alpha, plays a role in inflammatory responses through binding to the receptors CCR1, CCR4 and CCR5. Polymorphisms at this locus may be associated with both resistance and susceptibility to infection by human immunodeficiency virus type 1.[provided by RefSeq, Sep 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.